Eris Lifesciences Limited has informed the Exchange about Link of Recording
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eris Lifesciences has informed the exchanges that the recording of its earnings conference call held on May 19, 2025, discussing the audited standalone and consolidated financial results for Q4 and FY ending March 31, 2025, is now available on the company's website. The filing was made by Milind Talegaonkar, Company Secretary, as a compliance disclosure under SEBI Listing Regulations. The document itself contains no financial numbers or management commentary — it only shares a link to the recording.
This is a routine regulatory compliance filing with no direct impact on the stock price. Investors interested in management's views on margins, guidance, or strategy for FY26 should listen to the actual earnings call recording for substance.